
--- Page 1 ---
Dg I 1cs-6-3 caucnema, ni pi1tnatng !obitin:Nos"8530]3 Sits: Erast. Nos c50.9 UUID:810663DD-1718-4FD6-B9C2-77B4C091B3F1 TCGA-AC-A23G-01A-PR Redacted Collected Recelved: Accessio! Reported: Aoct/Rg SURGICAL PATHOLOGY REPORT DIAGNOSISA J.s, excision: B. Right breast, masteclomy: "Areas of anglolymphatc Invaslon suggested. No in situ component Identified. Histologically unremarkable nipple and negative inked deep surgical margin of resection. Background of prollferative fibrocystic changes inciuding moderate usual ductal hyperplasla and a single mlcroscopic focus of atypical ducta!  hyperplasia. Ancillary studies previously obtained. C. Right axillary contents, reglonal resection: Metastatic adenocarclnom eayxtsotstsyaaroarse The largest lymph node shows a multifocal microgranulomatous reaction associated wth refractile foreign material. Staging sheet #25 Stage: T1cN1MX, stage iIa : Electronic Signature:  ClInICAl hIstoRy: Preoperative Diagnosis: Right breast cancet Postoperative Dlagnosis:  Symptoms/Radtologic Findings: Crite epanc SPECIMENS: A. Right axillary sentinel nodes 8. Right breast C. Right axllary contents SQU.ALIF!E Gross DescrIptIOn: A. The first contalnes Ais labeled were examined at the time of surgery and are subsequently entirely submitted In cassettes  and conslsts of two lymph nodes measuring 1.2 x 1.0 x 0.5 cm and 1.5 x 1.2 x 0.5 cm. The lymph nodes B. The'second contalner 8 is labeled. s follows: FSA1--1; FSA2--2.  inked and sectioned with attached skin measuring 25.0 x 15.0 x 6.0 cm and weighs 830 grams. The skin surface measures 20.0 x 9.0 cm and Is iight nd right breast and consists of a portion of fibroadipose breast tissue that has been received previously tan wrinkied. There is an area discolored by blue contast dye surrounding the nipple measuring 6.0 cm. The nipple is centrally placed and appears  grossty normal. The specimen has orlented wilh a suture at superior. On sectloning there is a firm gray-tan fibrous mass measuring 1.2 x 1.0 x 0.7 cm that is 1.0 cm from the deep margin of resecton and is located predominanty within the upper inner quadrant. Tha surrounding breast tissue reveals epresentative sectlons are submitted in cassettes  nasssectonsfo Om upper Inner quadrant--7; lower Inner quadrant--; lower outer quadrant-; upper outer quadrant--10.  as follows: nipp!e--1; sections from mass--2 C. The third container C is labeled. Sectioning reveals twelve probable lymph nodes measuring from 0.2 to 1.5 cm. The lymph nodes are entirely submitted in cassette. Ad right axillary contents and consists of a portion of fibroadlpose tissue measuring 8.0.x 5.5 x as

--- Page 2 ---
foltows: five probable nodes--1; six probable nodes-2; one lymph node trisected--3 and 4. InTrA-OPERATIVE COnSULTATION:E FSA: 'Metastatic neoplasm in at leasl one of the two lymph noxdes.

--- Page 3 ---
to be rofered to a breast surgeon; Patient was called with results and will followup withj necossary surgloal refexral Hor the *r*END OF ADDENBUM ** VOICR TO TEXT SYNOPSIS ADDENDUM *** Invasive lobular carcinoma/Patient needs to be refeqred to a surg :ADS: (6) Known blopsy - proven malignancy +BND OP ADDENDUM *** FULL RESULT: Indication: Right breast rnassktntansoand guldrarsarstaiops Vacuum-asslsted uitrasound-guided 'core biopsy: Scana through the right breast at 1:00 agaln confirm a solld Irregular mass. It has shadowing posterlory. Following local anesthesla, a 10-gauge Cassi device was Introduced into tha mass under ultresound guldance. using vacuum asslstance, multiple core samp!es were obtalned. Procedure was woll tolerated. Clip placement: Under ultrasound guidance, a biopsy cilp was Inserted percutaneously into the area of the mass. Thls was successtully deployed under uitrasound guldance. Right mammogram, post procedure: A postbiopsy mammogram was obtained. Thla confirms placement of the biopsy marker clip. It is well within the spiculated mass in the upper inner quadrant. ImpRESSiON: Irregular solld mass right breast at  deployed successfully into the blopsy site. Pathology pending.: . Ultrasound-guided vacuum-assisted core blopsy performed. Cllp

--- Page 4 ---
Collected: Accession #: Received. Acct / Rog #: 1 Reported: SURGICA PATHOLOGYREPORT ADDENDUM REPORT ADDENDUM REPORT NUMBER TWO BrEAst pRoGnostic PanEL: Biock 2 Test RESULT REFERENCE RANGES DNA Analysi. by Jmage:* DNA Index: SEE COMMENI 0.9 -1.1 is Diplold  0.9 or > 1.1 i Aneuplold COmuent: insufficient tumor volume is present for quantitation of DnA by iImage analysit. Her2 Gene Anplification By FISH: NEGATIVE Averaga copies per cali: Her-2/nou: 1.82 Chromosome 17: 1.67 Ratio: 1.09 > 20 Har2/neu Case interpretad by? Notes: *Quantitative analysis performed using Chromavlsion ACis.d The Har2 /neu and CEP17 probee are manufactured by Vysis inc.d The Her2/neu gene detecton by Fluoreecence in Situ Hybridization (Fish} was porformod using the LSl Her?/neu DNA probe, specific for the Her2ineu gene locue 17q11.2-q12 and the CEp1 DNA probe specific for the aipha satellite DNA sequence at the centromoric - reglon of chromosome 17 (17p11.1-q11.1) Thoee tosts were developed and porformance characteristics determined by the.d They heve not been cieared or approved by the Us Food and Orug Administration. The FoA has detarmined that such approval or ciearance is not neceseary. Thoes tauts ars used for dinicai purpoeee. They showld not be regarded as inveetigetional or for reeearch. This  aboratory is certified under the Clinical Laboratory Improvement Act (CtiA} of 1sss a quaAtiad to perform high complexity cnicad. laboratory testing. Piace of Servlce: Center for Advanced Diagnostic. Addandun Report Irsuod By: ADDENDUM REPORT NUMBER ONE BRmAst PROGNOsTIC PAnEL: (Pre!minary test r*sults on biock A2).d TEST RESULT REFERENCE RANGES Estrogen Receptor: POSme (94%) > 4% 1s Positive 2.4% Is Borderline < 2% Is Nagative Progesterone Receptor: POS(TYE (69%) > 4% is Pozitive 2-4% is Borderine < 2% Is Negative Kl-67 (MI81) Proliferaton Marker: BQRDERLINE (18%) > 20% Is High t0-20% is Bordertine <10% is Low REPORTCONTINUDONN

--- Page 5 ---
PATIENT INFORMATION These resuits were Interpretod by Drdd An additiona! addendum report will follow wten DNA and Her-2-neu testsd are completed. These tests were developed and performance characteristics dotermined by. hey have not been cloared or approved by. the Us Food and Drug Adrninistration. The FDA hxs dotormined that auch approvai or clearance is not necessary. Theee tests are ueed for clinlcal purposes. They should not be regarded as investigational or for research. This laboratory Is certified under the Clnicai Laboratory Improvement Act (CtiA) of 198s as qualifiod to perfom hignh complaxity clinicai Iaboratory testing. Addendum Reoort Issued By: DIAGNOSIS: Invasive lobular carcinoma.d Stxe: Two cores partially involved witn largest linear dkntntion 5 mm as measured trom slide A2. Elston modification of Bloom-Richardson Grude: Architectural score: 3/3. Nuclear score: 2/3. Mitote score: 1/3. Total score: 6/9-. No In situ carcInoma component prosont. No iymphovascular space invasion evident. No microcalcificatone soen. No other signiflcant proliferative breast disease pattern present.d Paraftin Biock A2 subnitted for breast cancer prognostio panel with resuits reported as an addendum (pararin block A5 suitable if additional material necessary).d Electronlc Signature: CLINICAL INFORMATION CLinIcal histoRy: Preoperative Disgnosis: Core noodie biopsy, true cut, ulrasound core biopsy ancllary toet # mallgnant Estrogen/Progosterone recoptors, Her2-nou Postoperative Dlagnosis: Symptoma/Radioioglc Findings: Mamnogram, uXresound, size trregular mass 1 x 2 cm SPECIMENS: Right breast SPECIMENDATA Gross Description: Rocetved in one container labeled :  ight breasl are muitiple (15 to 20) sot pait yoigw wispy fragnonts and conm measuring up to 1.2 cm in. greatest dimension. The specinen is entrety submitted in five cassettes labeled Cass color blue.